Effect of Discharge Via an Intermediate Care Unit

This study is currently recruiting participants.

Verified December 2012 by Norwegian University of Science and Technology

Sponsor:

Information provided by (Responsible Party):

Norwegian University of Science and Technology

ClinicalTrials.gov Identifier:

NCT01706744

First received: October 11, 2012

Last updated: December 4, 2012

Last verified: December 2012

History of Changes

Tracking Information

First Received Date ^ICMJE

October 11, 2012

Last Updated Date

December 4, 2012

Start Date ^ICMJE

February 2010

Estimated Primary Completion Date

June 2014 (final data collection date for primary outcome measure)

Current Primary Outcome Measures ^ICMJE

Hospital readmission [ Time Frame: 30 days ] [ Designated as safety issue: No ]
Acute admission to hospital within 30 days from previous discharge
Use of local health care services [ Time Frame: up to 1 year ] [ Designated as safety issue: No ]

Original Primary Outcome Measures ^ICMJE

Same as current

Change History

Complete list of historical versions of study NCT01706744 on ClinicalTrials.gov Archive Site

Current Secondary Outcome Measures ^ICMJE

death [ Time Frame: up to 1 year ] [ Designated as safety issue: No ]
hospital admission [ Time Frame: up to 1 year ] [ Designated as safety issue: No ]
functional assessment status [ Time Frame: up to 6 months ] [ Designated as safety issue: No ]
Health service cost [ Time Frame: up to 1 year ] [ Designated as safety issue: No ]

Original Secondary Outcome Measures ^ICMJE

Same as current

Current Other Outcome Measures ^ICMJE

Not Provided

Original Other Outcome Measures ^ICMJE

Not Provided

Descriptive Information

Brief Title ^ICMJE

Effect of Discharge Via an Intermediate Care Unit

Official Title ^ICMJE

Can Discharge Via an Intermediate Care Unit Prevent Aggravation of Disease and Loss of Functionality, Without Increasing the Level of Cost? A Controlled Observational Study

Brief Summary

The main goal is to investigate the following topics:

Can discharge via the Intermediate Care Unit in Stjørdal, compared to direct discharge to Verdal Municipality, be equally effective in preventing aggravation of disease and loss of function for patients over 60 years that have been hospitalized in Levanger hospital?
Are the cost by discharge to the Intermediate Care Unit in Stjørdal, when the hospital is not located in the same Municipality, comparable to the cost by direct discharge to the Municipality of Verdal, for patients over 60 years that have been hospitalized in Levanger hospital?
Which issues are considered important by patients and health personnel during discharge, arrival and follow up in the Municipality, to ensure an optimal interaction between the involved units.

Detailed Description

Not Provided

Study Type ^ICMJE

Interventional

Study Phase

Not Provided

Study Design ^ICMJE

Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention

Condition ^ICMJE

Patients
Aged

Intervention ^ICMJE

Other: Intermediate care unit
Other: Local health care 1
Other: Local health care 2

Study Arm (s)

Experimental: Intermediate care unit
Follow-up treatment and care in a intermediate care unit after discharge from hospital

Intervention: Other: Intermediate care unit
Active Comparator: Local health care 1
Discharge from hospital to usual care as provided by the local health and social care (Verdal)

Intervention: Other: Local health care 1
Active Comparator: Local health care 2
Discharge from hospital to usual care as provided by the local health and social care (Stjørdal)

Intervention: Other: Local health care 2

Publications *

Not Provided

* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.

Recruitment Information

Recruitment Status ^ICMJE

Recruiting

Estimated Enrollment ^ICMJE

130

Estimated Completion Date

October 2014

Estimated Primary Completion Date

June 2014 (final data collection date for primary outcome measure)

Eligibility Criteria ^ICMJE

Inclusion Criteria:

Patients 60 years old or older from Stjørdal- or Verdal municipality,

given consent,
admitted from their home,
diagnostics completed and necessary treatment started
the patient need not less than 3-4 days institutionalization for treatment/rehabilitation/care

Exclusion Criteria:

Patients with severe dementia
Patients with severe disease who cannot give consent
Patients with severe disease with short life expectancy (including severe cancer)

Gender

Both

Ages

60 Years and older

Accepts Healthy Volunteers

Contacts ^ICMJE

Contact: Unni A Dahl	+4797762465	unni.dahl@ntnu.no
Contact: Aslak Steinsbekk, PhD, prof	+4773597574	aslak.steinsbekk@ntnu.no

Location Countries ^ICMJE

Norway

Administrative Information

NCT Number ^ICMJE

NCT01706744

Other Study ID Numbers ^ICMJE

2009/1697

Has Data Monitoring Committee

Responsible Party

Norwegian University of Science and Technology

Study Sponsor ^ICMJE

Norwegian University of Science and Technology

Collaborators ^ICMJE

Not Provided

Investigators ^ICMJE

Study Director:

Roar Johnsen, PhD

Norwegian University of Science and Technology

Information Provided By

Norwegian University of Science and Technology

Verification Date

December 2012

^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP

To Top